0001214659-21-000146.txt : 20210105 0001214659-21-000146.hdr.sgml : 20210105 20210105175257 ACCESSION NUMBER: 0001214659-21-000146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniels Mark CENTRAL INDEX KEY: 0001753840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 21507534 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-50803.xml PRIMARY DOCUMENT X0306 4 2020-12-31 0001581280 Twist Bioscience Corp TWST 0001753840 Daniels Mark C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false See Remarks Common Stock 2020-12-31 4 M false 1166 26.66 A 69953 D Common Stock 2020-12-31 4 S false 1166 152.13 D 68787 D Common Stock 2021-01-04 4 F false 153 141.29 D 68634 D Common Stock 2021-01-04 4 M false 669 10.70 A 69303 D Common Stock 2021-01-04 4 S false 669 138.61 D 68634 D Employee Stock Option (right to buy) 26.66 2020-12-31 4 M false 1166 0 D 2028-11-18 Common Stock 1166 39676 D Employee Stock Option (right to buy) 10.70 2021-01-04 4 M false 669 0 D 2028-02-01 Common Stock 669 8022 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary /s/ William Solis, as Attorney-in-Fact for Mark Daniels 2021-01-05